Browser not compatible.
Your computer's internet browser may not be compatible with this system. In order to use this system properly, you will need to update your current browser version or use another compatible browser version such as: Internet Explorer 8+, Mozilla Firefox 4+, Safari 5+, Chrome 14+, Opera 11.5+. Thank you.
Your session will expire in:

Advances in Inflammatory Bowel Diseases

Better Together in IBD 2021

December 9-11, 2021

Instructions to Submitters
  • Every new user MUST begin by creating a new account.
  • Please ensure all email addresses for all participants are correct.
  • Inactivity of more than 90 minutes on the system pages will result in a session time out. Please save your pages intermittently to avoid loss of data.
  • For technical assistance, please click on the 'Support Form' icon located on the top right hand of each page for support. Support requests are answered within a 24 hour period.
  • Once you are finished, please click on ‘finalize submission’ on the final page to complete your submission.
  • Submitters may revisit the site as often as necessary to edit your submission.
  • Please use one of the following browsers:  Mozilla Firefox 4+, Safari 5+, Chrome 14+, Opera 11.5+ and Edge 87.  For users of Internet Explorer, Compatibility View must be turned off. Please refer to: for more information.
  • Browser back and forward arrows have been disabled.  Users must use the page progress bar located at the top left of each page.
  • **Please note** In order to successfully receive emails regarding your abstract submission, you must add '' as a safe sender in your email client.  Click here for help adding safe senders for Outlook.  Mail client examples include Microsoft Outlook, IBM Lotus Notes, Pegasus Mail, Mozilla's Thunderbird, etc.
Participants interested in presenting data should submit abstracts online by September 19, 2021, 11:59 PM ET. Abstracts are subject to acceptance by the Scientific Review Committee. Accepted abstracts will be published in the American Journal of Gastroenterology and accepted for poster display at the  2021 AIBD conference, December 9-11 in Orlando, Florida. Only abstracts received by the submission deadline will be published. Acceptance notifications will be sent on or before October 4, 2021.

Abstracts will be accepted in the following categories: CLINICAL, SURGERY, PEDIATRIC, NURSING/APP, or YOUNG INVESTIGATOR. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

C1. Outcomes Research
C2. Clinical Trials and IBD Therapies
C3. Procedures and Diagnostics
C4. Case Reports

N. Nurses/Advanced Practice Providers

S.  Surgery

P. Pediatrics

Y. Young Investigator

Abstract Guidelines
Please follow the online instructions.

Accepted format:
  • ‚ÄčAbstracts must be in English
  • 9-point Arial font
  • 500-word count limit
  • Use a concise title in title case only.  (Example:  This is the Title of my Presentation)
  • List affiliations of author(s) as briefly as possible, with city, state/province and country
    • The system can accommodate up to 20 total authors
  • Use standard and well-accepted abbreviations
  • When listing references, use standard and well-accepted formats
  • Abstract content should be single-spaced and typed in lower case; abstract title should not include any formatting
  • Abstracts shall be of original research and contain a concise statement of study aim
  • No uploaded tables or graphs please
  • Please include the following four (4) parts of your abstract:
    •  Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable
    •   Incomplete abstracts will not be accepted
Previous Presentation, Publication and Duplication of Abstracts:
  • Encore abstracts will be allowed if they contain new data. During the submission process you will be asked if the abstract has been presented before, when you say yes you will be prompted to submit the original abstract as a reference
  • Abstracts will not be considered for presentation if they have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline
  • Abstracts will not be considered for presentation if they have been duplicated in any way
  • Abstracts may not be submitted to more than one category
  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster presentation, are eligible for submission but must contain new, additional information to be considered
  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author
Poster Abstract Awards
Abstracts are reviewed and accepted by the AIBD Scientific Review Committee. Each year the AIBD Scientific Review Committee recognizes the “Best Of” submitted abstracts. Winning abstracts receive free conference registration and a $500 scholarship to help off-set associated travel expenses. Abstract awards are given for the following categories: Clinical, Surgery, Pediatric, Nursing/APP, and Young Investigator.

Submission of an abstract constitutes a commitment by the author(s) to 1) submit an appropriately formatted abstract poster to showcase in the AIBD poster hall, and 2) conduct an oral presentation if selected as the winning abstract for the category (i.e., Best of Surgery Abstract). Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2021 Advances in IBD Conference.

The conference will withdraw abstracts upon written notification from the submitting author by October 15, 2021. Acceptance of the abstract obligates the author to present the paper.

Please contact the system administrator at for any abstract questions.  Please ensure your email address is included in the message.